| P2093 | author name string | Henry H Wortis | |
| | Iris Z Jaffe | |
| | Pilar Alcaide | |
| | Nicholas C Bene | |
| P2860 | cites work | Refining the role of B cells in atherosclerosis | Q84379092 |
| | Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes | Q87091235 |
| | Aging-associated cardiovascular changes and their relationship to heart failure | Q27024178 |
| | Alternative activation of macrophages | Q27860939 |
| | Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated | Q28281477 |
| | Mechanisms of mineralocorticoid action | Q28281657 |
| | The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 |
| | Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1 | Q28585931 |
| | The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation | Q29617813 |
| | Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors | Q30528005 |
| | Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction | Q33642021 |
| | T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses | Q33819043 |
| | Mineralocorticoid action. | Q33819647 |
| | Mineralocorticoid selectivity: molecular and cellular aspects | Q33888900 |
| | Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway | Q33903180 |
| | The role of aldosteronism in causing obesity-related cardiovascular risk | Q33995992 |
| | The role of inflammatory and fibrogenic pathways in heart failure associated with aging. | Q34061245 |
| | Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. | Q34090097 |
| | Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 |
| | Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells | Q34331407 |
| | T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein | Q34390132 |
| | Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol | Q34522261 |
| | Inflammation, immunity, and hypertension | Q34528283 |
| | Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 |
| | Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia | Q34591546 |
| | Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure | Q34620874 |
| | Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications | Q34684861 |
| | Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research | Q34788452 |
| | Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment | Q35552966 |
| | Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction | Q36229028 |
| | Expanding the effector CD4 T-cell repertoire: the Th17 lineage. | Q36449975 |
| | Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells | Q36478492 |
| | Adaptive immunity in atherogenesis: new insights and therapeutic approaches | Q36497196 |
| | Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism | Q36701794 |
| | Mechanisms of cardiac fibrosis in hypertension | Q36873139 |
| | Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion | Q37003229 |
| | Regulation of T-cell function by endogenously produced angiotensin II. | Q37100479 |
| | IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 |
| | 11β-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-/- mice | Q37687153 |
| | Role of the adaptive immune system in hypertension | Q37694853 |
| | Mechanisms of cardiac fibrosis in inflammatory heart disease. | Q37743971 |
| | Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells | Q37849362 |
| | Mineralocorticoid receptors in vascular function and disease | Q37896953 |
| | Immune modulation of resistance artery remodelling | Q37899280 |
| | Protective role of natural IgM-producing B1a cells in atherosclerosis | Q38030251 |
| | The immune system: role in hypertension | Q38035608 |
| | Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease | Q38103479 |
| | IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation | Q38297511 |
| | Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells | Q38330461 |
| | Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone | Q40559994 |
| | Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study. | Q40812995 |
| | Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension | Q41956748 |
| | Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure | Q42457579 |
| | The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure | Q42468951 |
| | Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. | Q42829877 |
| | Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. | Q43233439 |
| | Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study | Q43691886 |
| | Eplerenone in patients with systolic heart failure and mild symptoms | Q44272913 |
| | Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice | Q44459362 |
| | Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study | Q44601096 |
| | Distinguishing the antihypertensive and electrolyte effects of eplerenone | Q44924306 |
| | IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. | Q45968562 |
| | Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis | Q46372665 |
| | A Nuclear Receptor Atlas: macrophage activation | Q46506122 |
| | Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis | Q47677228 |
| | Regulatory T cells ameliorate angiotensin II-induced cardiac damage | Q47721821 |
| | Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure | Q49106538 |
| | Lentivirus mediated IL-17R blockade improves diastolic cardiac function in spontaneously hypertensive rats. | Q50521732 |
| | Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. | Q50761727 |
| | Widespread Myocardial Inflammation and Infarct-Related Artery Patency | Q58230268 |
| | Local Amplification of Glucocorticoids by 11 -Hydroxysteroid Dehydrogenase Type 1 Promotes Macrophage Phagocytosis of Apoptotic Leukocytes | Q61865359 |
| | Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor | Q67494059 |
| | Parallel determination of mineralocorticoid and glucocorticoid receptors in T- and B-lymphocytes of human spleen | Q69833633 |
| | Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque | Q69990504 |
| | Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism | Q81661632 |
| | T regulatory lymphocytes prevent aldosterone-induced vascular injury | Q82831987 |
| | T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury | Q83288251 |
| | Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice | Q83567632 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 38-45 | |
| P577 | publication date | 2014-04-21 | |
| P1433 | published in | Steroids | Q15716675 |
| P1476 | title | Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease. | |
| P478 | volume | 91 | |